165 related articles for article (PubMed ID: 33797339)
1. COVID19-inhibitory activity of withanolides involves targeting of the host cell surface receptor ACE2: insights from computational and biochemical assays.
Kalra RS; Kumar V; Dhanjal JK; Garg S; Li X; Kaul SC; Sundar D; Wadhwa R
J Biomol Struct Dyn; 2022 Oct; 40(17):7885-7898. PubMed ID: 33797339
[TBL] [Abstract][Full Text] [Related]
2. Withanone from
Balkrishna A; Pokhrel S; Singh H; Joshi M; Mulay VP; Haldar S; Varshney A
Drug Des Devel Ther; 2021; 15():1111-1133. PubMed ID: 33737804
[TBL] [Abstract][Full Text] [Related]
3. Identification of bioactive molecule from
Tripathi MK; Singh P; Sharma S; Singh TP; Ethayathulla AS; Kaur P
J Biomol Struct Dyn; 2021 Sep; 39(15):5668-5681. PubMed ID: 32643552
[TBL] [Abstract][Full Text] [Related]
4. Withanolides from
Khanal P; Chikhale R; Dey YN; Pasha I; Chand S; Gurav N; Ayyanar M; Patil BM; Gurav S
J Biomol Struct Dyn; 2022 Aug; 40(12):5295-5308. PubMed ID: 33459174
[TBL] [Abstract][Full Text] [Related]
5. Anti-COVID-19 Potential of Withaferin-A and Caffeic Acid Phenethyl Ester.
Kumar V; Sari AN; Gupta D; Ishida Y; Terao K; Kaul SC; Vrati S; Sundar D; Wadhwa R
Curr Top Med Chem; 2024; 24(9):830-842. PubMed ID: 38279743
[TBL] [Abstract][Full Text] [Related]
6. Withaferin A: a potential therapeutic agent against COVID-19 infection.
Straughn AR; Kakar SS
J Ovarian Res; 2020 Jul; 13(1):79. PubMed ID: 32684166
[TBL] [Abstract][Full Text] [Related]
7. Organic cultivation of Ashwagandha with improved biomass and high content of active Withanolides: Use of Vermicompost.
Kaur A; Singh B; Ohri P; Wang J; Wadhwa R; Kaul SC; Pati PK; Kaur A
PLoS One; 2018; 13(4):e0194314. PubMed ID: 29659590
[TBL] [Abstract][Full Text] [Related]
8.
Singh M; Jayant K; Singh D; Bhutani S; Poddar NK; Chaudhary AA; Khan SU; Adnan M; Siddiqui AJ; Hassan MI; Khan FI; Lai D; Khan S
Front Cell Infect Microbiol; 2022; 12():933824. PubMed ID: 36046742
[TBL] [Abstract][Full Text] [Related]
9. Differential activities of the two closely related withanolides, Withaferin A and Withanone: bioinformatics and experimental evidences.
Vaishnavi K; Saxena N; Shah N; Singh R; Manjunath K; Uthayakumar M; Kanaujia SP; Kaul SC; Sekar K; Wadhwa R
PLoS One; 2012; 7(9):e44419. PubMed ID: 22973447
[TBL] [Abstract][Full Text] [Related]
10. Withanone and Withaferin-A are predicted to interact with transmembrane protease serine 2 (TMPRSS2) and block entry of SARS-CoV-2 into cells.
Kumar V; Dhanjal JK; Bhargava P; Kaul A; Wang J; Zhang H; Kaul SC; Wadhwa R; Sundar D
J Biomol Struct Dyn; 2022 Jan; 40(1):1-13. PubMed ID: 32469279
[TBL] [Abstract][Full Text] [Related]
11. Structure-activity relationship (SAR) and molecular dynamics study of withaferin-A fragment derivatives as potential therapeutic lead against main protease (M
Ghosh A; Chakraborty M; Chandra A; Alam MP
J Mol Model; 2021 Feb; 27(3):97. PubMed ID: 33641023
[TBL] [Abstract][Full Text] [Related]
12. Targeting COVID-19 (SARS-CoV-2) main protease through active phytochemicals of ayurvedic medicinal plants -
Shree P; Mishra P; Selvaraj C; Singh SK; Chaube R; Garg N; Tripathi YB
J Biomol Struct Dyn; 2022 Jan; 40(1):190-203. PubMed ID: 32851919
[TBL] [Abstract][Full Text] [Related]
13. Subcritical water extraction of withanosides and withanolides from ashwagandha (Withania somnifera L) and their biological activities.
Nile SH; Nile A; Gansukh E; Baskar V; Kai G
Food Chem Toxicol; 2019 Oct; 132():110659. PubMed ID: 31276745
[TBL] [Abstract][Full Text] [Related]
14. Metabolite Profiling in Withania somnifera Roots Hydroalcoholic Extract Using LC/MS, GC/MS and NMR Spectroscopy.
Trivedi MK; Panda P; Sethi KK; Jana S
Chem Biodivers; 2017 Mar; 14(3):. PubMed ID: 27743505
[TBL] [Abstract][Full Text] [Related]
15. Withanolides against TLR4-Activated Innate Inflammatory Signalling Pathways: A Comparative Computational and Experimental Study.
Purushotham PM; Kim JM; Jo EK; Senthil K
Phytother Res; 2017 Jan; 31(1):152-163. PubMed ID: 27859734
[TBL] [Abstract][Full Text] [Related]
16. Effect of Ashwagandha Withanolides on Muscle Cell Differentiation.
Wang J; Zhang H; Kaul A; Li K; Priyandoko D; Kaul SC; Wadhwa R
Biomolecules; 2021 Oct; 11(10):. PubMed ID: 34680087
[No Abstract] [Full Text] [Related]
17. Withania somnifera and Its Withanolides Attenuate Oxidative and Inflammatory Responses and Up-Regulate Antioxidant Responses in BV-2 Microglial Cells.
Sun GY; Li R; Cui J; Hannink M; Gu Z; Fritsche KL; Lubahn DB; Simonyi A
Neuromolecular Med; 2016 Sep; 18(3):241-52. PubMed ID: 27209361
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanism of anti-SARS-CoV2 activity of Ashwagandha-derived withanolides.
Dhanjal JK; Kumar V; Garg S; Subramani C; Agarwal S; Wang J; Zhang H; Kaul A; Kalra RS; Kaul SC; Vrati S; Sundar D; Wadhwa R
Int J Biol Macromol; 2021 Aug; 184():297-312. PubMed ID: 34118289
[TBL] [Abstract][Full Text] [Related]
19. Optimization of elicitation conditions with methyl jasmonate and salicylic acid to improve the productivity of withanolides in the adventitious root culture of Withania somnifera (L.) Dunal.
Sivanandhan G; Arun M; Mayavan S; Rajesh M; Jeyaraj M; Dev GK; Manickavasagam M; Selvaraj N; Ganapathi A
Appl Biochem Biotechnol; 2012 Oct; 168(3):681-96. PubMed ID: 22843063
[TBL] [Abstract][Full Text] [Related]
20. Analysis of medicinal and therapeutic potential of
Gheshlaghi SZ; Nakhaei E; Ebrahimi A; Jafari M; Shahraki A; Rezazadeh S; Saberinasab E; Nowroozi A; Hosseini SS
J Biomol Struct Dyn; 2023; 41(14):6883-6893. PubMed ID: 35993530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]